Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Randox Wins NI Hospital Trusts Business

Published: Monday, December 09, 2013
Last Updated: Monday, December 09, 2013
Bookmark and Share
Randox fought off global competition to win a five year contract to supply quality control products to the Northern Ireland Health & Social Care Trusts.

The contract will see the County Antrim firm supply quality control products to all ten hospitals within the NI Trusts. The new business is worth potentially £1.2m over the life of the contract. 

The deal means that routine patient blood tests carried out in any NHS hospital or clinic in Northern Ireland will be quality assured by Randox products developed and manufactured in Crumlin.

A high percentage of medical appointments in Northern Ireland result in patient blood samples being taken before being tested in laboratories. Diagnosis of an illness or medical condition, and the subsequent treatment prescribed, will be given by a doctor based on the results of these blood tests.

Robust Quality Control is the bedrock of patient blood testing as it helps laboratories ensure accuracy in their testing procedures. If errors occur during testing this can result in misdiagnosis and delayed treatment, which can ultimately be life threatening for the patient. 

Randox is one of the largest manufacturers of laboratory quality control products in the world. The products, all manufactured in Country Antrim, are widely considered to be the most accurate quality controls available globally. As part of the deal Randox has developed a range of customised quality controls specifically to match the clinical requirements of the NI Hospital Trusts.

Health Minister Edwin Poots, who visited Randox today as part of the announcement, said, 

“Northern Ireland’s biotechnology sector is world-class and a growing contributor to the local economy.  I am delighted that patients in Northern Ireland will now benefit from quality assured diagnostic products developed and manufactured in Crumlin.  

“Today's announcement is a further example of the positive mutual benefits to health and the economy that can result from partnership working between Government and the Pharmaceutical and Biotechnology Industry. I am keen to continue this work to ensure that we can continue to grow our pharmaceutical and biotechnology capacity in Northern Ireland.”

Steven Jordan Global Manager, Randox Quality Control lauded the positive contribution the company is making in improving the health of Northern Ireland’s population and, ultimately, saving lives.

“Randox’s reputation as a leader in diagnostics is recognised across the world. We are a ground-breaking biotechnology company, committed to revolutionising healthcare and diagnostics at a global level. We are delighted that the people of Northern Ireland will now be able to benefit from this level of global expertise, ensuring more accurate and reliable diagnosis, and improving the health outlook for all.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

UK Trade and Investment Joins Hands with Randox
UK Trade and Investment organize healthcare seminars in Pakistan on “Improving Healthcare and Laboratory performance in Pakistan.”
Thursday, May 30, 2013
Newly Launched RIQAS Website Makes EQA Even Simpler for Laboratories Worldwide
www.riqas.com allows users to easily discover the many benefits offered by the world’s largest External Quality Assessment (EQA) scheme, Randox International Quality Assessment Scheme (RIQAS) and the advantages of implementing EQA in their laboratory.
Monday, March 04, 2013
You Don’t have to be a Scientist to Work in Healthcare
Randox is expanding its workforce with the recent recruitment of 42 individuals throughout October and November.
Thursday, November 15, 2012
Randox Opens New Manufacturing Facility in Bangalore, India
New Bangalore manufacturing facility to enhance product quality, ensure on time delivery and generate excellent customer satisfaction.
Friday, April 27, 2012
Scientific News
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Accelerating the Detection of Foodborne Bacterial Outbreaks
The speed of diagnosis of foodborne bacterial outbreaks could be improved by a new technique developed by researchers at the Georgia Institute of Technology.
Cancer Gene Predicts Treatment Response in Leukaemia
Study indicates the patients suffering from a lethal for of acute myeloid leukemia may live longer when receiving milder chemotherapy drugs.
New Diagnostic Tool for Familial Mediterranean Fever
A new tool developed by researchers at VIB and Ghent University could improve the process of diagnosing Familial Mediterranean Fever.
'Lab on the Skin' for Sweat Analysis
Northwestern University researchers develop a low-cost wearable electronic device that collects and analyzes sweat for health monitoring.
Molecular Signature for Aggressive Brain Tumor Uncovered
Researchers have identified genetic mutations in a highly agressive brain cancer that distinguishes the agressive, from the benign forms of the cancer.
Malaria Parasite Evades Rapid Test Detection in Children
A study at the University of North Carolina found that gene deletion poses a threat to Malaria eradication efforts.
Novel Urine Test to Predict High-Risk Cervical Cancer
Preliminary studies affirm accuracy and potential cost savings to screen for virus-caused malignancy.
GFC Diagnostics Wins Longitude Prize Discovery Award
The global award was won for the development of a cheap, quick and simple MRSA Test.
Understanding Circulating Tumour Cells
Research team develops new tool to track traveling cancer cells in the bloodstream.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!